9 | Monoclonal AntibodiesIBA
10/2020
-
07/2009 |
9 | Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2020
-
01/2012 |
7 | PolymersIBA
10/2021
-
09/2016 |
6 | Coloring Agents (Dyes)IBA
01/2020
-
03/2012 |
6 | ErbB Receptors (EGF Receptor)IBA
08/2015
-
01/2012 |
5 | Trastuzumab (Herceptin)FDA Link
10/2020
-
01/2012 |
5 | Peptides (Polypeptides)IBA
01/2020
-
11/2015 |
5 | Proteins (Proteins, Gene)FDA Link
01/2019
-
01/2012 |
5 | Matrix Metalloproteinases (MMPs)IBA
01/2018
-
07/2009 |
5 | Panitumumab (Vectibix)FDA Link
08/2015
-
01/2012 |
4 | Therapeutic UsesIBA
01/2022
-
05/2013 |
4 | Contrast MediaIBA
12/2016
-
09/2014 |
4 | Matrix Metalloproteinase 14 (MT1-MMP)IBA
12/2015
-
07/2009 |
3 | Amyloid (Amyloid Fibrils)IBA
01/2022
-
01/2016 |
3 | Liposomes (Liposome)IBA
01/2022
-
01/2013 |
3 | Drug CarriersIBA
10/2021
-
03/2016 |
3 | GoldIBA
10/2021
-
01/2020 |
3 | Indium-111IBA
10/2021
-
01/2018 |
3 | Edotreotide (SMT 487)IBA
03/2021
-
07/2015 |
3 | human ERBB2 proteinIBA
10/2020
-
01/2017 |
3 | Radioisotopes (Radionuclides)IBA
01/2020
-
01/2017 |
3 | Immunoglobulin G (IgG)IBA
01/2017
-
12/2011 |
3 | Immunoglobulin FragmentsIBA
12/2016
-
10/2013 |
3 | Pharmaceutical PreparationsIBA
01/2014
-
01/2013 |
3 | Fluorescent Dyes (Fluorescent Probes)IBA
10/2013
-
10/2011 |
3 | phthalocyanineIBA
05/2013
-
03/2012 |
2 | LipidsIBA
01/2022
-
01/2021 |
2 | Ga(III)-DOTATOCIBA
03/2021
-
07/2019 |
2 | fluoromisonidazoleIBA
01/2021
-
03/2016 |
2 | Prostaglandins AIBA
01/2021
-
11/2014 |
2 | Indicators and Reagents (Reagents)IBA
01/2018
-
07/2014 |
2 | RadiopharmaceuticalsIBA
01/2018
-
01/2013 |
2 | Pentetic Acid (DTPA)FDA LinkGeneric
11/2014
-
12/2011 |
2 | Human Serum AlbuminFDA LinkGeneric
09/2014
-
02/2014 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2014
-
01/2013 |
2 | Galactose (Galactopyranose)FDA LinkGeneric
03/2014
-
02/2014 |
2 | Daunorubicin (Cerubidine)FDA LinkGeneric
02/2014
-
01/2013 |
2 | Photosensitizing Agents (Photosensitizers)IBA
02/2014
-
01/2013 |
2 | progelatinaseIBA
10/2011
-
07/2009 |
1 | Amyloidogenic ProteinsIBA
01/2022 |
1 | SodiumIBA
01/2022 |
1 | Congo RedIBA
01/2022 |
1 | AA amyloidosisIBA
01/2022 |
1 | liposomal doxorubicin (Doxil)FDA Link
01/2022 |
1 | amyloid enhancing factorIBA
01/2022 |
1 | thioflavin TIBA
01/2022 |
1 | Sulfates (Sulfates, Inorganic)IBA
09/2021 |
1 | Chondroitin Sulfates (Chondroitin Sulfate)IBA
09/2021 |
1 | Fibroblast Growth Factor-23IBA
03/2021 |
1 | Poly(amidoamine)IBA
01/2021 |
1 | Iodine-125IBA
01/2021 |
1 | Dendrimers (Dendrons)IBA
01/2021 |
1 | CarbonIBA
01/2021 |
1 | Polyglutamic Acid (Polyglutamate)IBA
01/2021 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2021 |
1 | PolyethyleneimineIBA
01/2021 |
1 | IntegrinsIBA
01/2020 |
1 | Excipients (Suspending Agents)IBA
01/2020 |
1 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2019 |
1 | Biomarkers (Surrogate Marker)IBA
01/2019 |
1 | Islet Amyloid PolypeptideIBA
12/2018 |
1 | AmidesIBA
01/2018 |
1 | dibenzofuranIBA
01/2018 |
1 | Carbonic Anhydrase IXIBA
01/2018 |
1 | CarbamatesIBA
01/2018 |
1 | Pancreatic Elastase (Elastase)IBA
01/2018 |
1 | SulfonamidesIBA
01/2018 |
1 | Antisense OligonucleotidesIBA
01/2018 |
1 | MorpholinosIBA
01/2018 |
1 | GW 4869IBA
09/2017 |
1 | Molecular Probes (Molecular Probe)IBA
01/2017 |
1 | IronIBA
01/2017 |
1 | 4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2017 |
1 | polysarcosineIBA
01/2017 |